| abstract |
The present invention provides means and methods for the treatment of diffuse large B cell lymphoma (DLBCL). In particular, bispecific CD19 x CD3 antibodies (ie bispecific T cell conjugates, which bind to T cells through their CD3 binding and at the same time to CD19 on the surface of lymphoma cells, in particular through their CD19 binding, " BiTE ") is administered for use in the treatment of tumor masses of lymphatic reticulum tissue and / or extralymphatic lymphoma caused by DLBCL in a patient. |